The T32 Training Program in Cancer Biology at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC) is a multidisciplinary fellowship training program supported by the NIH (T32CA) that focuses on basic and translational cancer research with the ultimate goal of enhancing clinical oncology. The training program provides cross-disciplinary, mentored research training in cancer, and supports overall professional development through seminars, journal clubs, workshops, and career development. Clinical and basic research is conducted in several laboratories within UMGCCC. An overview of UMGCCC's extensive research programs can be found on the Research Programs page. The program is well-suited to individuals who are highly motivated to seek broader training in addition to the traditional single lab-focused postdoctoral experience.

Research areas include:

  • Cancer genomics
  • Cancer and the microbiome
  • Computer-aided drug design
  • Structural biology
  • Experimental therapeutics and drug resistance in leukemias
  • Tumor immunology and immunotherapy
  • Genetic modification of hematopoietic stem cells
  • Proteolytic signaling mechanisms in inflammation, tumor and vascular biology

The T32 training program provides a competitive stipend commensurate with qualifications, travel, health insurance, and tuition remission. Appointments to the training grant will be for two years, with the possibility of an extension for another year depending on productivity; support for additional years may be available from the primary research mentor’s grants.  

Interested candidates should send or email a letter of intent and Curriculum Vitae to:

UMB Cancer Biology T32 Training Grant
c/o Leanne Simington, MS
University of Maryland Baltimore
Medical Science Training Facility
10 S. Pine Street
3-57W, Room 3-57J
Baltimore, MD 21201

Program Directors: Toni Antalis, PhD and Curt Civin, MD

Email address:

Qualifications for T32 Training Grant

Postdoctoral fellowships are intended for scientists who have a doctoral degree (PhD, MD, MD/PhD, PharmD, DDS or equivalent) or are in the process of completing a doctoral degree. Candidates should have a strong commitment to a career in cancer research.

In accordance with the NIH NRSA eligibility, the candidate must be a United States citizen or permanent resident. Members of underrepresented minority groups are strongly encouraged to apply.

For more information about the T32 Training Grant, visit the Cancer Biology T32 Training Program page at the University of Maryland School of Medicine website.